Opladen-Quettingen, undefined

Karl Heinrich Mayer


Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 82(Granted Patents)


Location History:

  • Opladen-Quettingen, DE (1976 - 1977)
  • Opladen, DE (1977)
  • Leverkusen, DE (1977 - 1980)

Company Filing History:


Years Active: 1976-1980

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Karl Heinrich Mayer

Introduction

Karl Heinrich Mayer, an inventive mind hailing from Opladen-Quettingen, Germany, is known for his significant contributions to the field of pharmaceuticals with a total of five patents to his name. His innovations focus on developing compounds that act on the central nervous system, showcasing his commitment to advancing medical science.

Latest Patents

Mayer's latest patents include groundbreaking work on Benzodiazepine-diones, which cover compounds with complex formulas that exhibit potential as medicaments. These compounds have utility as tranquilizers and antiamnesics, highlighting their importance in treating conditions related to mental health. The invention also details methods for producing these compounds and their applications in medical compositions.

Another notable patent is in the realm of 3-Carbo(lower alkoxy)hydrazinoindazoles, where Mayer has developed 3-hydrazinoindazoles acylated with a carbo(lower alkoxy) group. These compounds serve as analgesic, anti-inflammatory, and antipyretic agents, with 3-carbomethoxyhydrazino-6-chloroindazole being a prominent example. The compounds are synthesized through innovative processes involving treatment with derivatives of carbonic acid.

Career Highlights

Mayer's career is marked by his tenure at Bayer Aktiengesellschaft, a multinational pharmaceutical and life sciences company where he has had the opportunity to explore his innovative ideas. His work has significantly impacted the pharmaceutical industry, particularly in drug development.

Collaborations

Throughout his career, Mayer has collaborated with esteemed colleagues such as Friedrich Hoffmeister and Erich Klauke. These partnerships have fostered an environment of innovation and have led to the development of essential compounds that address various health challenges.

Conclusion

Karl Heinrich Mayer's contributions to the pharmaceutical field through his innovative patents reflect his dedication to advancing medical science. His work on Benzodiazepine-diones and hydrazinoindazoles stands as a testament to the vital role that inventors play in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…